RevMab Biosciences

Founded in 2012, RevMAb Biosciences USA, Inc. provides high-quality recombinant monoclonal antibody solutions for research and diagnostic customers. With a focus on recombinant antibody development without cell fusion or hybridoma generation, rabbit monoclonal antibody generation services, and antigen-specific B cell screening, and a portfolio of rabbit and goat monoclonal antibodies (including primary, secondary, and mutation-specific antibodies), RevMAb Biosciences USA, Inc. is committed to promoting personal health by accelerating biomedical research and advancing disease diagnosis. 

Cambridge Bioscience is pleased to provide RevMAb Biosciences USA, Inc. products in the UK and Ireland.